Ark Therapeutics plans UK listing for up to $57 million
This article was originally published in Clinica
Executive Summary
UK company Ark Therapeutics, which develops medical products and pharmaceuticals aimed at vascular disease and cancer, aims to raise £30-40 million ($43-57 million) through its flotation on the London Stock Exchange.